These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
905 related items for PubMed ID: 18482180
1. Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods. Luten M, Roerdinkholder-Stoelwinder B, Schaap NP, de Grip WJ, Bos HJ, Bosman GJ. Transfusion; 2008 Jul; 48(7):1478-85. PubMed ID: 18482180 [Abstract] [Full Text] [Related]
2. Transfusion of stored red blood cells adhere in the rat microvasculature. Chin-Yee IH, Gray-Statchuk L, Milkovich S, Ellis CG. Transfusion; 2009 Nov; 49(11):2304-10. PubMed ID: 19624601 [Abstract] [Full Text] [Related]
7. Survival of the fittest?--survival of stored red blood cells after transfusion. Luten M, Roerdinkholder-Stoelwinder B, Bost HJ, Bosman GJ. Cell Mol Biol (Noisy-le-grand); 2004 Mar; 50(2):197-203. PubMed ID: 15095790 [Abstract] [Full Text] [Related]
8. Storage duration and white blood cell content of red blood cell (RBC) products increases adhesion of stored RBCs to endothelium under flow conditions. Anniss AM, Sparrow RL. Transfusion; 2006 Sep; 46(9):1561-7. PubMed ID: 16965584 [Abstract] [Full Text] [Related]
9. Viability of AS-3 and SAG-M red cells stored in plastic syringes for pediatric transfusion. Podlosky L, Poirier A, Nahirniak S, Clarke G, Acker JP. Transfusion; 2008 Jul; 48(7):1300-7. PubMed ID: 18363582 [Abstract] [Full Text] [Related]
11. Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process. Cancelas JA, Dumont LJ, Rugg N, Szczepiorkowski ZM, Herschel L, Siegel A, Pratt PG, Worsham DN, Erickson A, Propst M, North A, Sherman CD, Mufti NA, Reed WF, Corash L. Transfusion; 2011 Nov; 51(11):2367-76. PubMed ID: 21569044 [Abstract] [Full Text] [Related]
17. Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients. van de Watering L, Lorinser J, Versteegh M, Westendord R, Brand A. Transfusion; 2006 Oct; 46(10):1712-8. PubMed ID: 17002627 [Abstract] [Full Text] [Related]
18. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Lapierre V, Aupérin A, Robinet E, Ferrand C, Oubouzar N, Tramalloni D, Saas P, Debaene B, Lasser P, Tiberghien P. Transfusion; 2007 Sep; 47(9):1691-9. PubMed ID: 17725736 [Abstract] [Full Text] [Related]
19. In vitro and in vivo evaluation of LEUKOSEP HRC-600-C leukoreduction filtration system for red cells. AuBuchon JP, Cancelas JA, Herschel L, Roger J, Rugg N, Pratt PG, Joines A, Gormas JF, Zia M, Spearman MR. Transfusion; 2006 Aug; 46(8):1311-5. PubMed ID: 16934065 [Abstract] [Full Text] [Related]
20. Infusion of P-Capt prion-filtered red blood cell products demonstrate acceptable in vivo viability and no evidence of neoantigen formation. Cancelas JA, Rugg N, Pratt PG, Worsham DN, Pehta JC, Banks K, Davenport RD, Judd WJ. Transfusion; 2011 Oct; 51(10):2228-36. PubMed ID: 21492178 [Abstract] [Full Text] [Related] Page: [Next] [New Search]